Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
0.7701
-0.0819 (-9.61%)
Sep 16, 2026, 4:00 PM EDT - Market closed
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $99.58 million as of September 16, 2026. Its market cap has decreased by -47.45% in one year.
Market Cap
99.58M
Enterprise Value
96.03M
1-Year Change
-47.45%
Ranking
Category
Stock Price
$0.77
ChartMarket Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has decreased from $145.96M to $99.58M, a decrease of -31.78%. That is a compound annual growth rate of -7.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 99.58M | -43.76% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 115.59M |
| Rani Therapeutics Holdings | 114.51M |
| Nautilus Biotechnology | 113.40M |
| Cellectis | 113.30M |
| Black Diamond Therapeutics | 113.18M |
| Vivani Medical | 110.95M |
| Genelux | 110.69M |
| Aardvark Therapeutics | 109.86M |